Raymond James Financial Services Advisors, Inc. Cassava Sciences Inc Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	SELL	$12.64 - $30.11 $55,603 - $132,453	-4,399 Reduced 30.41%	10,066 $226,000
Q3 2023 Oct 24, 2023	BUY	$16.64 - $25.32 $68,357 - $104,014	4,108 Added 39.66%	14,465 $240,000
Q2 2023 Jul 25, 2023	SELL	$21.59 - $27.88 $19,193 - $24,785	-889 Reduced 7.91%	10,357 $253,000
Q1 2023 Apr 14, 2023	BUY	$23.46 - $36.44 $48,327 - $75,066	2,060 Added 22.43%	11,246 $271,000
Q4 2022 Feb 08, 2023	BUY	$27.82 - $44.16 $25,510 - $40,494	917 Added 11.09%	9,186 $271,000
Q3 2022 Oct 25, 2022	SELL	$16.33 - $51.06 $16,509 - $51,621	-1,011 Reduced 10.89%	8,269 $346,000
Q2 2022 Aug 12, 2022	SELL	$17.22 - $38.47 $45,891 - $102,522	-2,665 Reduced 22.31%	9,280 $261,000
Q1 2022 May 11, 2022	BUY	$32.6 - $53.05 $119,968 - $195,224	3,680 Added 44.53%	11,945 $444,000
Q4 2021 Feb 08, 2022	BUY	$36.77 - $90.91 $93,175 - $230,365	2,534 Added 44.22%	8,265 $361,000
Q3 2021 Nov 02, 2021	BUY	$41.79 - $135.3 $77,520 - $250,981	1,855 Added 47.86%	5,731 $356,000
Q2 2021 Aug 11, 2021	BUY	$32.15 - $89.72 $124,613 - $347,754	3,876 New	3,876 $331,000

Others Institutions Holding SAVA

# of Institutions

190

Shares Held

16.4M

Call Options Held

3.49M

Put Options Held

8.08M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $114M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account